← Back to Search

Acquire Therapy for Microcephaly

N/A
Waitlist Available
Led By Stephanie C DeLuca, PhD
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Global Developmental Delay with Microcephaly or hyperkinetic movements.
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5-12 weeks
Awards & highlights

Study Summary

This study is evaluating whether intensive therapy may help improve motor function for children with developmental delays.

Eligible Conditions
  • Global Developmental Delay
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Microcephaly

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5-12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5-12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline on Motor Function Assessment
Secondary outcome measures
Change from baseline on Disability Assessment
Change from baseline on EEG power in alpha band.
Change from baseline on EEG power in beta band.
+10 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment InterventionExperimental Treatment1 Intervention
All children will receive 3-5 weeks of intensive neuromotor Acquire therapy, an operant conditioning, play based therapy that maximizes therapeutic movements, attention, and engagement.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acquire Therapy
2019
N/A
~10

Find a Location

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor
141 Previous Clinical Trials
27,762 Total Patients Enrolled
1 Trials studying Microcephaly
500 Patients Enrolled for Microcephaly
American Academy for Cerebral Palsy and Developmental MedicineUNKNOWN
1 Previous Clinical Trials
59 Total Patients Enrolled
Stephanie C DeLuca, PhDPrincipal InvestigatorVirginia Polytechnic Institute and State University
1 Previous Clinical Trials
18 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
BMC Research NotesJournal
A Clinical Series Using Intensive Neurorehabilitation to Promote Functional Motor and Cognitive Skills in Three Girls with CASK Mutation
DeLuca, Stephanie C., Dory A. Wallace, Mary Rebekah Trucks, and Konark Mukherjee. 2017. “A Clinical Series Using Intensive Neurorehabilitation to Promote Functional Motor and Cognitive Skills in Three Girls with CASK Mutation”. BMC Research Notes. Springer Science and Business Media LLC. doi:10.1186/s13104-017-3065-z.
clinicaltrials.govStudy
Intensive Therapy for Children With Microcephaly, Hyperkinetic Movements, or Global Developmental Delay
Stephanie DeLuca 2019. "Intensive Therapy for Children With Microcephaly, Hyperkinetic Movements, or Global Developmental Delay". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04816175.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top